A) Inflammability B) Toxicity C) Biocompatibility D) Corrosiveness
A) To block cell growth B) To provide a structure for cells to grow and organize C) To induce inflammation D) To prevent regeneration
A) Chemical stability B) Biodegradability C) Fatigue resistance D) Thermal conductivity
A) Corrosion B) High cost C) Heavy weight D) Biocompatibility
A) Increase toxicity B) Enhanced surface interactions and properties C) Decrease biocompatibility D) Reduce mechanical strength
A) Silicone rubber B) Hydroxyapatite C) Polyethylene D) PMMA
A) Macrophages B) Keratinocytes C) Fibroblasts D) Red blood cells
A) To increase toxicity B) To prevent infections C) To accelerate degradation D) To promote inflammation
A) Astrophysics B) Biomaterials science or biomaterials engineering C) Quantum mechanics D) Marine biology
A) Biological materials are always synthetic B) Biomaterials are engineered, while biological materials are naturally produced C) There is no difference between them D) Biomaterials cannot be used in medical applications
A) Pure water-based solutions B) Exclusively organic compounds C) Only natural fibers D) Metallic components, polymers, ceramics, or composite materials
A) Using only historical data without new testing B) Through random trial and error methods C) Exclusively through animal testing D) By computational routines predicting molecular effects based on limited in vitro experimentation
A) An assembly method that uses magnetic fields. B) A process requiring mechanical manipulation to form structures. C) The spontaneous aggregation of particles without external forces. D) The random distribution of particles in a solution.
A) The chemical composition of particles. B) The spatial scale of the unit cell (lattice parameter). C) The temperature at which assembly occurs. D) The external forces applied to the system.
A) Chemical bonding between particles. B) External guidance and control. C) Random particle distribution. D) Self-organization.
A) 1.5 nm. B) 70 to 100 nm. C) 3 nm. D) 60 nm.
A) About 60/40. B) 80/20. C) 50/50. D) 70/30.
A) Within the mineral phase only. B) On the surface of tropocollagen molecules. C) At the gaps between collagen fibrils. D) Randomly throughout the matrix.
A) 60 nm diameter canals. B) 1 μm diameter rods. C) 20 to 30 nm layers. D) "Bricks" with dimensions of 0.5.
A) Hydroxyapatite. B) Calcium carbonate. C) Collagen. D) Chitin.
A) An amorphous structure. B) A helical pattern. C) A random distribution. D) A cubic pattern.
A) 1 μm. B) 60 nm. C) 70 to 100 nm. D) 20 to 30 nm.
A) ISO 9001 B) ISO 27001 C) ISO 10993 D) ISO 14001
A) Amino acids B) Fatty acids C) Nucleotides D) Sugars
A) Bone graft substitute B) Dental filling material C) Heart valve coating D) Artificial skin scaffold
A) Pyrolytic carbon B) Calcium sulfate C) Polyethylene terephthalate D) Stainless steel
A) Synthetic polymers B) Plant fibers C) Animal skin D) Metal wires
A) 10 different configurations B) 20 different configurations C) 14 different configurations D) 5 different configurations
A) Kevlar B) Nylon C) Spandex D) Dacron
A) Foreign body response (FBR) B) Immune response C) Inflammatory reaction D) Healing process
A) Ultra-structure level B) Sub atomic level C) Molecular level D) Microstructure level
A) 25% B) 49% C) 75% D) 60%
A) Non-biodegradable B) Chemically reactive C) Electrically conductive D) Mechanically strong
A) 1 μm. B) 20 to 30 nm. C) 60 nm. D) 3 nm.
A) 1.5 nm. B) 70 to 100 nm. C) 3 mm. D) Approximately 60 nm.
A) Biofabrication B) Biocompatibility C) Biomimetics D) Biodegradation
A) 1980s B) Early 1950s C) Later 1960s D) 2000s
A) Bone strengthening B) Tissue growth stimulation C) Drug delivery D) Wound closure
A) Acute phase B) Resolution phase C) Chronic phase D) Healing phase
A) Non-degradable B) Brittle C) Biocompatible D) Toxic
A) Size B) Alignment C) Elasticity D) Shape
A) Liposomes B) Polymers C) Silica D) Polyetheretherketone (PEEK)
A) Starch B) Proteins C) DNA D) Cellulose
A) Macrophages B) Lymphocytes C) Neutrophils D) Eosinophils
A) Biocompatibility B) Acute inflammation only C) Foreign body response D) Graft-versus-host disease
A) Skin repair devices B) Joint replacements C) Contact lenses D) Dental implants
A) The implant B) Only the damaged tissue C) No structures are isolated D) Immune cells
A) Silk B) Cellulose C) DNA D) Starch
A) Biodegradable B) Non-biodegradable C) Inert D) Toxic
A) Tensile strength B) Ductility C) Flexural rigidity D) Young's Modulus
A) Cyclic olefin polymer (COP) B) Polypropylene (PP) C) Polycarbonate (PC) D) Polyetherimide (PEI)
A) Direct the immune response rather than circumvent it B) Elicit a strong immune reaction C) Avoid any interaction with the immune system D) Suppress the immune response entirely
A) Compressive strength B) Toughness C) Flexural rigidity D) Elasticity
A) Stainless steel B) Aluminum C) Ivory D) Ceramic
A) Scanning Electron Microscopy B) Mass Spectrometry C) Nuclear Magnetic Resonance D) X-ray Diffraction
A) Line defects B) Point defects C) Macrostructure D) Edge dislocation |